Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in children with Osteogenesis Imperfecta
NCT00106028Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Nov 2004
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of risedronate in osteogenesis imperfecta (OI), sponsored by Warner Chilcott. Started Nov 2004; status: completed.
02
Drugs
risedronate
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT00106028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106028.